Actively Recruiting
Study of Self-Compassion and Self-Efficacy in People Aged 40 to 85 With Parkinsons Disease and Their Impact on Symptoms and Quality of Life
Led by Acibadem University · Updated on 2026-07-15
100
Participants Needed
1
Research Sites
12 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study investigates how self-compassion and self-efficacy relate to symptom severity, functional ability, and quality of life in adults diagnosed with Parkinsons disease. The research aims to better understand these psychological factors in people living with Parkinsons disease stages 1 to 3, within an age range of 40 to 85 years. Participants will complete a set of self-report questionnaires during one session to assess their levels of self-compassion, self-efficacy, symptom severity, functional status, and quality of life. No therapeutic treatments or interventions are provided. The study collects data at a single time point to analyze associations among these outcomes. During the study visit, participants will be assessed with various scales and tests including the Self-Compassion Scale, Self-Efficacy for Managing Chronic Disease scale, Unified Parkinsons Disease Rating Scale, Timed Up and Go test, Six-Minute Walk test, Mini-Balance Evaluation Systems Test, and Parkinsons Disease Questionnaire-39. These assessments help evaluate physical function, symptoms, and quality of life. The study is led by Acibadem University and participation involves completing questionnaires and physical tests in one session.
CONDITIONS
Brief Title
"Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life"
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of Parkinson's disease
- Hoehn and Yahr stage 1-3
- Age 40 to 85 years
- Mini-Mental State Examination (MMSE) score 24 or higher
- Sufficient cognitive function to communicate and complete study assessments
- Attending the Movement Disorders Outpatient Clinic, Department of Neurology
- Able and willing to provide written informed consent
You will not qualify if you...
- Major depressive disorder or psychotic disorder
- Advanced dementia
- Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension)
- Severe cardiovascular or respiratory disease
- Additional neurological or orthopedic conditions that may affect assessment performance
- Severe visual or hearing impairment that could interfere with study assessments
- Inability to cooperate with the physiotherapist during study assessments
Research Team
N
Nuray ALACA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here